Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medicare Walks Back Proposed Payment Policy For 505(b)(2) Physician Administered Drugs

Dec 02 2020

• By Cathy Kelly

Infusion of a hospital — Effort Targeted At Part B Drug Costs

Related Content

Medicare Proposed Part B Payment Policy For 505(b)(2) Drugs Is Illegal, Biopharma Argues

Oct 13 2020

Additional Topics

United States Reimbursement Pricing Strategies Government Payers Policy Review Pathway BioPharmaceutical

More from Medicare

More from Government Payers

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.